This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,513 Years Active: 2022
Title: Innovations in Hepatitis Diagnosis by Pil Sang Park
Introduction
Pil Sang Park is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the area of liver diseases. His innovative work focuses on developing tools that can aid in the early detection and monitoring of chronic hepatitis and liver fibrosis.
Latest Patents
Pil Sang Park holds a patent for a "Kit for tracking and diagnosing degree of progressive chronic hepatitis and liver fibrosis by measuring asialo (alpha)1-acid glycoprotein as hepatocellular injury marker and use thereof." This invention provides a rapid and easy method to test for initial liver disease. It specifically utilizes a monoclonal antibody for α1-acid glycoprotein, allowing for the diagnosis of progressive chronic hepatitis and liver fibrosis by measuring the concentration of asialo-α1-acid glycoprotein (AsAGP) in a sample. The kit is designed to determine the degree of liver disease from a blood sample, utilizing an immunochromatography strip that includes a conjugate specifically binding to asialo α1-acid glycoprotein.
Career Highlights
Throughout his career, Pil Sang Park has focused on innovations that enhance medical diagnostics. His work has been instrumental in providing healthcare professionals with tools that facilitate early intervention in liver diseases. His dedication to research and development has led to advancements that can significantly impact patient outcomes.
Collaborations
Pil Sang Park has collaborated with notable colleagues, including WangJo Cha and Hyunhyo Suh. These partnerships have contributed to the successful development and implementation of his innovative diagnostic kits.
Conclusion
Pil Sang Park's contributions to the field of liver disease diagnostics exemplify the importance of innovation in healthcare. His patented technology not only aids in early detection but also enhances the understanding of chronic hepatitis and liver fibrosis. The impact of his work is expected to improve patient care and outcomes in the medical community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile